Get Started

Raise 1M-10M+ For Your Therapeutic, Medical and Tech R&D And Expansion

Capital raising approach that gives you unfair advantage. We help you identify investor-messaging fit, setup an infrastructure that connects you to the best-fit investors, and help facilitate deals and DD.

Get Started
Explore Our Thesis

Over $1 Trillion worth of investors.

Here's what you can achive with the system we use :

We help you raise capital effectively in the shortest amount of time possible regardless of stages, regions, and market conditions.
Book Your Call
Investor
0 +
Institutional Investors
0 +
In Deals
$ 0 +
In Investment Introductions
$ 0 +

Who We Work With?

Biotech

Drug Discovery, Genetic Research, Biopharmaceuticals, Vaccine Development, Regenerative Medicine.

Medtech

Medical Devices, Diagnostic Equipment, Wearable Health Tech, Surgical Instruments, Robotic Surgery.

Services

Hospitals, Specialty Clinics, Long-term Care Facilities, Telehealth Services, Home Healthcare.

Health IT

Electronic Health Records (EHRs), Health Information Exchanges (HIEs), Telemedicine Platforms, Mobile Health Applications, Clinical Decision Support Systems (CDSS).

PROCESS

Dive Deeper Into Our Process

01 - Solving For Investor Segment
Identify and segment investor types based on key variables like stage, valuation, and industry, compiling a curated list of mandate-specific investors using proprietary technology and personal networks. Further, granular firm and individual identification ensures precision targeting for effective outreach efforts and investor commitments.
02 - Solving For Presentation
Phase 2 involves crafting and refining all marketing collateral, including presentation decks and video presentations, to effectively communicate the fund's value proposition to LPs. It emphasizes concise messaging, visual aids, and storytelling techniques to enhance engagement and comprehension. Distribution through online channels amplifies visibility and reach.
03 - Solving Introductions
Phase 3 focuses on leveraging existing networks and strategic outreach to facilitate introductions with potential investors. This includes private server email campaigns, personalized outreach creation, and content optimization. Additionally, expanding reach through LinkedIn campaigns and targeted outreach to LPs ensures engagement with relevant parties, maximizing opportunities for successful connections.
04 - Solving For Conversions
Phase 4 emphasizes building on introductions by conducting pre-meeting due diligence on investors, assigning an analyst to introductory calls, and refining materials and communication based on prospect feedback and initial conversations. This ensures a tailored approach, maximizing the potential for successful engagement and progression toward investment agreements.
05 - Solving For Deal Closure
Phase 5 focuses on deal closure by establishing a comprehensive data room, minimizing hold-ups during due diligence, and expediting the overall process. Attention to detail ensures completeness and accessibility of documentation, addressing investor concerns preemptively.
Previous slide
Next slide

VERTICALS / 03

Investor Verticals We Work
With

Institutional Investors

These are sophisticated entities such as banks, insurance firms, and pension funds, characterized by their substantial capital base and rigorous investment protocols. Institutional investors prioritize stable, long-term returns and typically engage in diversified investment portfolios.

Accredited Retail Investors

Accredited retail investors are individuals who meet stringent financial criteria outlined by regulatory bodies. They possess the financial capacity to participate in private investment opportunities not accessible to the general public. Accredited retail investors pursue higher-yield prospects, often embracing a heightened risk tolerance.

High Net Worth Individuals (HNWI)/Angels

HNWIs, distinguished by their considerable wealth, actively engage in direct investments, particularly in nascent ventures, as angel investors. Apart from financial backing, they offer valuable expertise, networks, and mentorship. HNWIs and angels seek opportunities that align with their risk appetite and strategic interests.
Book Your Call

VERTICALS / 03

Investor Verticals We Work With

These are sophisticated entities such as banks, insurance firms, and pension funds, characterized by their substantial capital base and rigorous investment protocols. Institutional investors prioritize stable, long-term returns and typically engage in diversified investment portfolios.
Accredited retail investors are individuals who meet stringent financial criteria outlined by regulatory bodies. They possess the financial capacity to participate in private investment opportunities not accessible to the general public. Accredited retail investors pursue higher-yield prospects, often embracing a heightened risk tolerance.
HNWIs, distinguished by their considerable wealth, actively engage in direct investments, particularly in nascent ventures, as angel investors. Apart from financial backing, they offer valuable expertise, networks, and mentorship. HNWIs and angels seek opportunities that align with their risk appetite and strategic interests.

Book Your Call Today

Unlock Innovative Access to Global Capital with Direct Channels to Over 10 Million Institutional, Accredited Retail, and Angel Investors
Book Your Call

@ 2024 Apex Ascension Inc. All Rights Reserved. 

  • Follow Us :
  • Follow Us :